20/20 Biolabs, Inc. Common Stock (AIDX) ownership: Streeterville Capital, LLC 75% · institutions 3% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Cresset Asset Management, LLC | 264368.00 | $497012.00 | 2.5% | 2026-03-31 |
| Citadel | 16227.00 | $30507.00 | 0.2% | 2026-03-31 |
| XTX Topco Ltd | 10329.00 | $19419.00 | 0.1% | 2026-03-31 |
| UBS | 8314.00 | $15631.00 | 0.1% | 2026-03-31 |
| MAI Capital Management | 1000.00 | $1880.00 | 0.0% | 2026-03-31 |
| Toth Financial Advisory Corp | 157.00 | $296.00 | 0.0% | 2026-03-31 |
| Allworth Financial LP | 30.00 | $57.00 | 0.0% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-03-03 | |
| Sell | null | 2026-03-03 | |
| Sell | null | 2026-02-19 | |
| Sell | null | 2026-02-19 |
Back to AIDX overview · AIDX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.